More Motrin recalled by J&J; slow dissolving blamed
This article was originally published in Scrip
Executive Summary
In what have been almost monthly occurrences for Johnson & Johnson and its McNeil Consumer Healthcare division in the past couple of years, the company issued yet another recall of its medicines – this time for about 12 million bottles of its over-the-counter (OTC) ibuprofen product Motrin.